Agilent Technologies has expanded its collaboration with Monash University Malaysia (MUM) for the establishment of a ...

Viatris has signed definitive agreements for the sale of its equity stake in Biocon Biologics to Biocon for $815m.

Opinions amongst the CDC's ACIP were divided on the continued use of the hepatitis B vaccine in a paediatric population.

The UK becomes the latest country in President Donald Trump’s long line of trade agreements, though it is the first region to ...

The strategic partnership sees two separate financial deals for the pair of oncology assets. Rights to Kelun’s integrin ...

By analyzing real-world data, digital health organizations can gain insights into actual costs, measure outcomes, and build ...

If approved, Regeneron and Tessera's TSRA-196 could become the first curative therapy to reach patients with AATD, who have ...

Høeg’s appointment to director of the FDA's CDER follows a turbulent period for the department, which has seen five leaders ...

With $1.5 billion in drug sales, the US dominated the CKD-HPT, HP and HK market in 2024, representing 59.7% of 7MM sales.

Patient advocacy and industry bodies welcomed the bill’s backing, though it will now need to be passed in the Senate.

AGC Biologics is set to expand its Cell Line Development Centre of Excellence through a partnership with ATUM.

Eli Lilly and Company has received approval from the US FDA for the expanded use of Jaypirca tablets in 100mg and 50mg doses.